XML 57 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings (Loss) Per Common Share
 12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Earnings (Loss) Per Common Share Earnings (Loss) Per Common Share

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
 
For the Years Ended December 31,
 
2019
 
2018
 
2017
Net loss
$
(305,580
)
 
$
(54,191
)
 
$
(69,767
)
Less:
 
 
 
 
 
Net loss attributable to non-controlling interests
(3,609
)
 
(1,533
)
 
(9,102
)
Net loss available for common shareholders - basic and diluted (1)
(301,971
)
 
(52,658
)
 
(60,665
)
 
 
 
 
 
 
Weighted-average common shares outstanding - basic and diluted (1)
82,364

 
77,338

 
64,351

 
 
 
 
 
 
Loss per common share
 
 
 
 
 
Basic and diluted
$
(3.67
)
 
$
(0.68
)
 
$
(0.94
)
(1) Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for one share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:
 
For the Years Ended December 31,
 
2019
 
2018
 
2017
Exchangeable Class B common stock
1,399

 
1,831

 
7,285

RSUs
813

 
1,027

 
525

Stock options
1,324

 
2,517

 
2,829

Convertible senior notes
10,361

 
6,176

 
5,201

Total
13,897

 
11,551

 
15,840